The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study
Crossref DOI link: https://doi.org/10.1186/s12933-015-0178-3
Published Print: 2015
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Paul, Sanjoy K
Klein, Kerenaftali
Maggs, David
Best, Jennie H
License valid from 2015-01-01